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Alphonsea sclerocarpa Thwaites belonging to the family Annonaceae is a small tree, which grows up to 10-15 m tall the 
leaves are simple and alternate. Despite its medicinal properties the plant seems to be less explored and hence this research 
aims at exploring the antiurolithiatic activity of ethanolic leaf extract of A. sclerocarpa on ethylene glycol induced 
urolithiasis in rats. A. sclerocarpa leaf powder was extracted using ethanol. The effect of ethanolic leaf extract of  
A. sclerocarpa (250 and 500 mg/kg, p.o.) was studied in experimentally induced renal stone in rats by in vivo model. 
Ethylene glycol model (0.75% in drinking water, for 28 days) was used for renal stone induction. The blood, urine and 
kidney samples were used for various parameters. The concentration of calcium, oxalate, phosphorus, creatinine and  
blood urea nitrogen was observed in each group. The phytochemical analysis was carried out to detect the presence of 
secondary metabolites like saponins and flavonoids in the ethanolic extract of A. sclerocarpa leaf extract. In ethylene glycol 
(0.75% v/v) treated animal model ethanolic extract of A. sclerocarpa leaf extract showed significant results on stone 
promoters (calcium oxalate, inorganic phosphate and sodium), kidney function parameters (uric acid, blood urea nitrogen, 
creatinine). On the basis of biochemical parameters and histopathological study it was confirmed that A. sclerocarpa leaf 
extract protected the renal cells from oxidative stress and injury induce by calcium oxalate crystals. The investigation of 
ethanolic extract of A. sclerocarpa leaf has shown promising antiurolithiatic activity and support folklore claims of these 
plants as antiurolithiatic. The mechanism of action of these plants for antiurolithiatic is apparently related to increased 
diuresis and lowering of urinary concentrations of stone-forming constituents, though it should be confirmed by the 
extensive exploratory studies. 
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Introduction 
Alphonsea sclerocarpa Thwaites belonging to the 
family Annonaceae is a small tree, which grows up to 
10-15 m tall the leaves are simple and alternate. The 
plant was explored for its antimicrobial, antioxidant, 
and antifungal
1
. Antibacterial and anticancer activity
2
. 
The study aims to report the antiurolithiatic activity of 
ethanolic leaf extract of A. sclerocarpa on ethylene 
glycol induced urolithiasis in rats. 
Kidney stones are one of the most painful urologic 
disorders. Renal stone affects 5 to 15% of adults. 
Epidemiological studies revealed that nephrolithiasis 
is more common in men (12%) than in women (6%) 
and is more prevalent between the ages of 20 to 40 in 
both sexes
3
 Urinary calculi is the third prevalent 
disorder in the urinary system. Urolithiasis is a 
common disease with an increasing incidence and 
prevalence worldwide that appears even more 
pronounced in industrialized countries
4
. Once 
recurrent, the subsequent relapse risk is raised and the 
interval between recurrences is shortened
5
. Features 
associated with recurrence include a young age of 
onset, positive family history, infection stones and 
underlying medical conditions
5
. Urolithiasis or 
nephrolithiasis represents the clinical condition of 
kidney stone disease. Stone formation in the urinary 
tract has been recognized for thousands of years, but 
during the last few decades, the pattern and incidence 
of the disease have changed markedly. Urinary stones 
affect 10–12% of the population in industrialized 
countries
5,6
. The incidence of urinary stones has been 
increasing over the last years while the age of onset is 
decreasing
7
. With a prevalence of > 10% and an 
expected recurrence rate of ~ 50%, the stone disease 
has an important effect on the healthcare system
8,9
. 
The aetiology of this disorder is multifactorial and is 
strongly related to dietary lifestyle habits or practices. 
——————— 
*Correspondent author 
Email: chandrumnrcop@gmail.com 
CHANDRASEKAR et al.: ANTIUROLITHIATIC ACTIVITY OF ALPHONSEA SCLEROCARPA  
 
 
253 
Most calculi in the urinary system arising from a 
common component of urine, e.g. calcium oxalate 
representing up to 80% of analyzed stones. In India, 
12% of the population is expected to have urinary 
stones, out of which 50% may end up with the loss  
of kidneys or renal damage. Also, nearly 15% of  
the population of northern India suffers from  
kidney stones
10
. 
Urolithiasis refers to the solid nonmetallic minerals 
in the urinary tract. Among the several types of 
kidney stones, the most common are calcium oxalate. 
The formation of these stones involves several  
physico-chemical events, beginning with crystal 
nucleation, aggregation, and ending with retention 
within the urinary tract
11
. 
Ethylene glycol (EG) is rapidly absorbed and 
metabolized in the liver via alcohol dehydrogenase/ 
aldehyde dehydrogenase to glycolic acid. Glycolic 
acid is oxidized to glyoxylic acid, which, in turn, is 
further oxidized to oxalic acid by glycolate oxidase. 
High doses of EG (>2,500 mg/kg body wt), 
particularly when given as an oral bolus, cause the 
saturation dependent accumulation of glycolic acid in 
the plasma. So, glycolate oxidase (GO) is one of the 
rate-limiting enzymes in the metabolism of EG
12
. 
 
Materials and Methods 
 
Chemicals and reagents 
Ethylene glycol was purchased from Merck Ltd., 
Mumbai, India. Cystone was obtained from  
Himalaya Health Care Pvt. Ltd. Various kits for 
biochemical estimation of urine and serum were 
purchased from Light care Diagnostics, Vijayawada 
India. All other chemicals and reagents used were 
analytical grade and procured from approved 
chemical suppliers.  
 
Plant collection and identification 
The leaves of A. sclerocarpa were collected from 
Thalakona, Tirupati, India. The plant was authenticated 
(Voucher No 1168) by Dr K. Madhava Chetty, Assistant 
Professor, Department of Botany, Sri Venkateswara 
University, Tirupati (India). 
 
Determination of physico-chemical parameters 
Determination of physico-chemical parameters 
such as total ash, acid insoluble ash, water-soluble 
ash, foreign organic matter and moisture content of 
the crude drug was determined according to WHO 
guidelines on quality control methods for medicinal 
plant materials (WHO, 1992)
13
.
  
Extraction procedure 
The leaves were washed and dried at room 
temperature (35 
o
C) for 7 days and then crushed into a 
coarse powder using a mixer grinder. The coarse 
powder was separated using sieve number 24.
 
The 
coarse powder was extracted using 100% ethanol at 
(45-50 
o
C). The coarse powder was packed in a 
muslin cloth and the extraction was carried out using 
soxhlet apparatus. The extraction process was 
continued for 120 hours. The ethanolic extract  
was concentrated on a boiling water bath and the 
solvent was evaporated until a semisolid mass was 
obtained. The wet mass was stored in a desiccator for 
further studies. The obtained powder was weighed 
and kept aside for phytochemical screening and 
pharmacological evaluation.
 
 
Preliminary phytochemical analysis 
The ethanolic extract was subjected to 
phytochemical analysis using a conventional  
protocol like alkaloids, flavonoids, carbohydrate and 
glycosides gums and mucilage, fixed oils, saponins, 
and proteins
14
. 
 
In vivo evaluation 
 
Animals 
Healthy male Wistar rats weighing 150–200 g  
were obtained from the central animal house  
facility of Liveon Biolabs Pvt. Ltd, Tumkur. Prior to 
initiation of the experiment, all the protocols were 
reviewed and approved by the Institutional Animal 
Ethics Committee (IAEC) (SHCP/IAEC/17-01 dt.  
25-12-2017) following guidelines of the Committee 
for the Purpose of Control and Supervision of 
Experiments on Animal (CPCSEA), Government of 
India. All the rats were randomly housed under 
hygienic conditions in polypropylene cages and 
allowed to acclimatize for one week. The animals 
were maintained at an ambient temperature of  
25±2 °C with proper ventilation with 12 h light and 
dark cycle. The animals were acclimatized to the 
laboratory conditions for one week prior to the 
experiments and provided with standard diet and 
water ad libitum. 
 
Acute toxicity studies 
Acute oral toxicity study for the test extract of the 
A. sclerocarpa was carried out as per the guidelines 
set by Organization for Economic Co-operation and, 
revised draft (OECD) 425 and by the CPCSEA, 
Ministry of Social Justice and Empowerment, 
Government of India. The study revealed that  
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the administration of ethanolic leaf extract of  
A. sclerocarpa was safe up to a dose of 2000 mg/kg. 
No death was observed up to this dose, and the 
experimental animals were physically active. Hence 
1/4
th 
(250 mg/kg) and 1/8
th
 (500 mg/kg), were selected 
as working doses for the present study
15
. 
 
Preparation of suspension of extracts 
The extracts were suspended in a dilute solution of 
Tween-80 before dosing.
 
 
Ethylene glycol induced urolithiasis 
Calcium oxalate urolithiasis was induced in 
experimental animals by administering ethylene 
glycol 0.75% (0.75 mL of ethylene glycol in  
100 mL of drinking water) to rats for a period  
of 28 days for the production of calcium oxalate  
stone in rats
16,17
.
 
 
Experimental design 
Animals were divided into five groups, each group 
containing 6 animals. Group 1 - normal control rats 
received normal pelleted diet, group 2 disease control 
received (0.75% v/v EG in drinking water; p.o) group 
3 received standard antiurolithiatic drug Cystone  
(750 mg/kg body weight) from 15
th
 to 28
th
 day, group 
4 – received ethanolic extract of the leaves  
of A. sclerocarpa leaf at a dose of 250 mg/kg body 
weight from 15
th
 to 28
th
 day respectively, group  
5 received ethanolic extract of the leaves of  
A. sclerocarpa leaf at a dose of 500 mg/kg body 
weight from 15
th
 day to 28
th
 day respectively. 
 
Grouping of Animals 
Animals were divided into five groups, each group 
containing 6 animals. Group 1 control rats received 
normal pelletted diet, group 2 disease control received 
0.75% v/v EG in drinking water; p.o. Group 3 
standard control received 0.75% v/v EG in drinking 
water+750 mg/kg Cystone; p.o. Group 4 received  
A. sclerocarpa ethanolic extract 250 mg/kg (0.75% 
v/v EG in drinking water+AsEe 250 mg/kg; p.o. 
Group 5 received A. sclerocarpa ethanolic extract  
500 mg/kg (0.75% v/v EG in drinking water+AsEe 
500 mg/kg; p.o.  
 
Study of biochemical parameters 
 
Collection and analysis of urine 
For the estimation of calcium and oxalate the rats 
were kept separately in metabolic cages and urine 
samples of 24 h were collected on 28th day. The urine 
samples were acidified with HCl. The acidified 
samples were titrated with 0.9494 N of KMNO4 till a 
light pink colour was obtained
18,19
.
 
 
Serum collection and analysis
 
After urine collection blood was collected 
retroorbitally from each rat under mild anesthetic 
condition and animals were sacrificed by cervical 
decapitation and serum was separated by 
centrifugation at 10,000 rpm for 10 minutes and 
analyzed for urea, uric acid, creatinine and calcium 
using commercially available diagnostic kits (Light 
Care Diagnostics, Vijayawada)
20-22
.  
 
Histopathological study of the rat kidney 
 
Preparation of kidney homogenate and biochemical estimation 
To confirm the incidence of lithiasis, the  
animals were sacrificed and their kidneys were 
subjected to histopathological studies. The abdomen 
was incised and opened, both kidneys were removed 
from each animal. Isolated kidneys were cleaned off 
extraneous tissue, weighed and rinsed with ice-cold 
normal saline. The left kidney was fixed with 10% v/v 
neutral formalin and after harvesting, sliced 
horizontally. Histological sections were prepared by 
microtomy and stained with hematoxylin-eosin 
(H&E) dye for histological examination, (Light Care 
Diagnostics, Vijayawada) for Hematoxylin and  
Eosin staining.
  
 
Data analysis 
The data obtained by the various parameters  
were statistically evaluated by one-way analysis  
of variance (ANOVA). The mean values±SEM  
were calculated for each parameter. P <0.05 was 
considered significant.
  
 
Results  
 
Physico-chemical parameters 
The determination of physico-chemical parameter 
is important in the determination of adulterants  
and improper handling of drugs. The result of the 
various physico-chemical parameters of powdered 
drug carried out using standard methods is shown in 
Table 1. The Phytochemical screening revealed the 
presence of alkaloids, saponins, tannins, steroids, 
anthocyanins, flavonoids and steroids.  
 
In vivo antiurolithiatic activity 
 
Ethylene glycol induced renal stone 
There was a significant decrease in animal weight 
and a significant increase in dry and wet kidney 
weight in ethylene glycol induced model control as 
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compared to control animals. Similarly, a significant 
decrease in urine output was observed in model 
control animals. These changes were significantly 
prevented as well as reversed by the treatment of  
A. sclerocarpa and cystone respectively. In normal 
control animals, urinary pH was found acidic. But in 
model control animals, urine was found alkaline in 
nature. Treatment of test and standard drugs 
significantly reduced urinary pH level. The effect of 
urine parameters are shown in Table 2 and Fig. 1.  
The effect of serum parameters are shown in Table 3 
and Fig. 2 whereas the effect of Kidney parameters 
are shown in Table 4 and Fig. 3. 
 
Histopathological evaluation of kidneys 
Histopathological examination of kidney section 
of normal control animals showed intact nephron 
structure. But in the model control group, there was 
significant damage to the kidney cells. Rupture of 
bowman’s capsule and tubules, as well as infiltration 
of cells, were observed with ethylene glycol  
treated animals. This damage was significantly 
prevented by four weeks of treatment of all test 
drugs and standard drug. Ethylene glycol induced 
damage was also reversed by two weeks treatment of 
A. sclerocarpa. The results of Histopathological 
Table 1 — Physico-chemical analysis of A. Sclerocarpa 
S. No. Evaluation  
parameters 
A. sclerocarpa leaf yield  
(% W/W) 
1 Total ash 5.804±0.321 
2 Water-soluble ash 1.042±0.062 
3 Acid insoluble ash 1.553±0.078 
4 Foreign organic matter 0.064±0.321 
5 Moisture content 10.802±0.728 
 
 
 
Fig. 1 — Effect of A. sclerocarpa treatment on urine parameters 
urine volume and urine pH 
 
 
 
Fig. 2 — Effect of A. sclerocarpa treatment on serum parameters 
uric acid, creatinine and BUN 
Table 2 — Effect of A. sclerocarpa on urine parameters on ethylene glycol induced urolithiasis in Wistar rats 
 Group 1  
Normal Control 
Group 2  
EG Induced 
Group 3  
EG + cystone Standard 
Group 4 Test-1 
AsEe 250 mg/kg 
Group 5 Test-2 
AsEe 500 mg/kg 
Urine volume 18.17±0.872 16.50±0.763 21.50±0.806** 22.17±0.872 ** 19.67±0.760 
Urine pH 6.52±0.092 8.08±0.071### 7.09±0.110*** 7.42±0.066*** 6.91±0.070*** 
All values are expressed as mean ± SEM (n = 6). Significance at ###P <0.001, ##P <0.01, #P <0.05 compared with normal control.  
***P <0.001, **P <0.01, *P <0.05 compared with EG group 
 
Table 3 — Effect of A. sclerocarpa in serum parameters on ethylene glycol induced urolithiasis in Wistar rats 
 Group 1  
Normal Control 
Group 2  
EG Induced 
Group 3  
EG + cystone Standard 
Group 4  
Test-1 AsEe 250 mg/kg 
Group 5  
Test-2 AsEe 500 mg/kg 
Uric acid 2.21 ± 0.165 7.63 ± 0.451### 3.12 ± 0.266*** 3.96 ± 0.266*** 2.65 ± 0.173*** 
BUN 34.37 ± 0.425 50.76 ± 1.043### 38.36 ± 0.595*** 41.18 ± 0.515*** 39.35 ± 0.438*** 
Creatinine 1.01±0.048 2.51±0.060 1.30±0.040*** 1.62±0.045*** 1.19±0.045*** 
(BUN -Blood Urea Nitrogen) 
All values are expressed as mean±SEM (n = 6). Significance at ###P <0.001 compared with normal control. ***P <0.001 compared with 
model control. 
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Evaluation of Kidney tissue of different groups are 
shown in Plate. 1. 
 
Discussion 
In the present study, male rats were selected  
to induce urolithiasis because the urinary system  
of male rats resembles that of humans. Urinary 
supersaturating with respect to stone-forming 
constituents is generally considered to be one of the 
causative factors in calculogenesis. Evidence in 
previous studies indicates that in response to 28 days 
period of ethylene glycol (0.75%, v/v) administration. 
Stone formation in ethylene glycol fed animals causes 
hypercalciuria, which causes increased renal retention 
and excretion of calcium. The glomerular filtration 
rate (GFR) is an important parameter for ensuring 
renal function and it gets decreased in urolithiasis due 
to the obstruction to the outflow of the urine by stones 
in the urinary system, which leads to a rise in 
nitrogenous waste products like urea, creatinine, and 
uric acid in blood
23
. 
In the present study, calcium excretion was 
progressively increased in calculi induced animals. 
Since, it is accepted that hypercalciuria is the 
significant risk factor in the pathogenesis of stone 
formation. Increased urinary calcium is a factor 
favouring the nucleation and precipitation of calcium 
phosphate from urine and subsequent crystal growth. 
The increased urinary excretion of calcium and 
oxalate levels in urolithiatic rats similar to that of 
uroltihiatic rats increased the excretion of calcium 
and oxalate
24
. 
However, supplementation with ethanolic extract 
of A. sclerocarpa at 500 mg/kg in group V 
significantly lowered the elevated levels of  
blood urea, uric acid in serum and calcium and 
oxalate in urine as compared to the group II and 
standard control
25
.  
The antiurolithiatic effect was further confirmed by 
kidney histopathological studies. Indeed, kidney 
sections of disease control showed abundant crystal 
deposition. Furthermore, renal epithelial cells had 
more tubular dilatation and damage shown by  
large spaces in the tissue. In groups III, IV and V 
fewer crystal depositions were seen compared to 
untreated animals and the necrosis, as well as the 
tubule dilatation, was very limited. Renal stone 
deposition damages the renal tissue and deteriorates 
the renal function
26
. 
Lithogenic treatment caused impairment of renal 
functions of the untreated rats. It was lowered in 
animals receiving treatment with A. sclerocarpa leaf 
extract. Tissue injury and inflammation in these 
animals is due to exposure to calcium oxalate crystals. 
The renal epithelial injury further promotes crystal 
retention, as epithelial injury exposes a variety of 
crystal adhesion molecules on epithelial surfaces and 
promotes stone formation. The constituents of  
A. sclerocarpa restored the renal function and 
prevented renal cell injury. 
 
Table 4 — Effect of A. sclerocarpa in kidney parameters on ethylene glycol induced urolithiasis in Wistar rats 
 Group 1 
Normal Control 
Group 2 
EG Induced 
Group 3 
EG + cystone Standard 
Group 4 
Test-1 AsEe 250 mg/kg 
Group 5 
Test-2 AsEe 500 mg/kg 
Calcium 9.25±0.213 13.46±0.316### 9.47±0.182*** 10.11±0.147*** 9.78±0.53*** 
Phosphate 3.99±0.128 9.74±0.361### 4.35±0.187*** 4.67±0.183*** 4.47±0.143*** 
Sodium 136.3±1.282 147.0±1.033### 140.3±0.666*** 141.0±0.365*** 138.8±0.477*** 
All values are expressed as mean±SEM (n = 6). Significance at ### P <0.001 compared with normal control. ***P <0.001, **P <0.01 
compared with model control. 
 
 
 
Fig. 3 — Effect of A. sclerocarpa treatment on kidney parameters 
calcium, phosphate and Sodium  
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Conclusion 
In the present investigation, the medicinal plant 
Alphonsea sclerocarpa was explored for its 
phytochemical nature and antiurolithiatic properties. 
The conclusion drawn from this investigation can be 
summarized as: Preliminary phytochemical screening 
of the drugs was carried out for the detection of 
different plant constituents. In ethylene glycol treated 
animal model, A. sclerocarpa (500 mg/kg, p.o.) 
showed significant results when compared with 
standard drug - cystone. It was also found to have 
significant prevention and reverse alteration in the 
kidney function parameters (uric acid, blood urea 
nitrogen and creatinine), when compared with cystone. 
In vivo treatment of ethanolic extract of  
A. sclerocarpa leaf extract has shown significant  
anti urolithiatic activity in ethylene glycol induced 
urolithiasis in rats. In histopathological examinations of 
the kidney also shows a reduction in renal damage with 
the treatment of ethanolic extract of A. sclerocarpa leaf 
extract. Hence, selected plant A. sclerocarpa leaf 
extract has shown promising antiurolithiatic activity 
and support folklore claims of these plants as 
antiurolithiatic. Urolithiasis is apparently related to 
increased diuresis and lowering of urinary 
concentrations of stone-forming constituents, though it 
should be confirmed by the extensive exploratory 
studies. Finally, future research is recommended on 
these leaves for authentication in human beings. 
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Plate 1 — Hematoxylin and eosin staining from animals of (a) normal control, (b) EG induced group, (c) EG+ cystone treated, (d) EeAs 
250 mg/kg, (e) EeAs 500 mg/kg. 
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